Edwards Lifesciences (EW) Return on Capital Employed (2010 - 2026)
Edwards Lifesciences' quarterly Return on Capital Employed came in at 11.13% in Q1 2026, down 110.0% year-on-year from 111.32% in Q1 2025, and up 2.77% quarter-over-quarter from 10.83% in Q4 2025.
Edwards Lifesciences has reported Return on Capital Employed for 17 years, with the latest figure at 11.13% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 110.0% year-over-year to 11.13%; the trailing twelve-month figure through Mar 2026 stood at 11.13% (down 110.0% YoY), and the FY2025 full-year result was 10.93%, down 327.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 11.13%, up from 10.83% in the prior quarter.
- The five-year high for Return on Capital Employed was 23.24% in Q1 2022, with the low at 10.83% in Q4 2025.
- Average Return on Capital Employed over 5 years is 16.07%, with a median of 15.7% recorded in 2024.
- Year-over-year, Return on Capital Employed jumped 888 bps in 2022 and plunged 671 bps in 2023.
- Tracing EW's Return on Capital Employed over 5 years: stood at 20.13% in 2022, then fell by 17 bps to 16.7% in 2023, then declined by 28 bps to 11.98% in 2024, then declined by 10 bps to 10.83% in 2025, then climbed by 3 bps to 11.13% in 2026.
- The last three Return on Capital Employed figures came in at 11.13% (Q1 2026), 10.83% (Q4 2025), and 12.09% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 5.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.13% |
| Dec 31, 2025 | 10.83% |
| Sep 30, 2025 | 12.09% |
| Jun 30, 2025 | 12.40% |
| Mar 31, 2025 | 12.23% |
| Dec 31, 2024 | 11.98% |
| Sep 30, 2024 | 14.73% |
| Jun 30, 2024 | 16.41% |
| Mar 31, 2024 | 15.70% |
| Dec 31, 2023 | 16.70% |
| Sep 30, 2023 | 15.29% |
| Jun 30, 2023 | 16.32% |
| Mar 31, 2023 | 19.59% |
| Dec 31, 2022 | 20.13% |
| Sep 30, 2022 | 22.00% |
| Jun 30, 2022 | 22.31% |
| Mar 31, 2022 | 23.24% |
| Dec 31, 2021 | 23.16% |
| Sep 30, 2021 | 24.01% |
| Jun 30, 2021 | 24.95% |
| Mar 31, 2021 | 14.36% |
| Dec 31, 2020 | 14.65% |
| Sep 30, 2020 | 14.86% |
| Jun 30, 2020 | 14.76% |
| Mar 31, 2020 | 22.23% |
| Dec 31, 2019 | 21.54% |
| Sep 30, 2019 | 16.63% |
| Jun 30, 2019 | 16.28% |
| Mar 31, 2019 | 16.21% |
| Dec 31, 2018 | 15.70% |
| Sep 30, 2018 | 23.89% |
| Jun 30, 2018 | 23.07% |
| Mar 31, 2018 | 23.55% |
| Dec 31, 2017 | 26.20% |
| Sep 30, 2017 | 20.85% |
| Dec 31, 2016 | 20.22% |
| Dec 31, 2015 | 18.42% |
| Dec 31, 2014 | 16.37% |
| Dec 31, 2013 | 20.32% |
| Dec 31, 2012 | 21.88% |
| Dec 31, 2011 | 11.14% |
| Sep 30, 2011 | 10.50% |
| Jun 30, 2011 | 11.19% |
| Mar 31, 2011 | 14.82% |
| Dec 31, 2010 | 13.66% |
| Sep 30, 2010 | 13.54% |